Enhancing sensitivity to PARP inhibitors

被引：0
|
作者：
Sarah Crunkhorn
机构：
来源：
Nature Reviews Drug Discovery | 2021年 / 20卷 / 6期
关键词：
D O I：
10.1038/d41573-021-00078-8
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：426 / 426
相关论文
共 50 条
  • [1] PARP Inhibitors Sensitivity and Resistance
    Helleday, T.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S58 - S58
  • [2] Enhancing Antitumor Effects of PARP Inhibitors
    Shumeyko, Emma P.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2016, 99 (06) : 575 - 575
  • [3] PARP inhibitors: enhancing efficacy through rational combinations
    Bhamidipati, Deepak
    Haro-Silerio, Jaime I.
    Yap, Timothy A.
    Ngoi, Natalie
    BRITISH JOURNAL OF CANCER, 2023, 129 (06) : 904 - 916
  • [4] PARP inhibitors: enhancing efficacy through rational combinations
    Deepak Bhamidipati
    Jaime I. Haro-Silerio
    Timothy A. Yap
    Natalie Ngoi
    British Journal of Cancer, 2023, 129 : 904 - 916
  • [5] Sensitivity and resistance biomarkers to PARP inhibitors in Mcrpc.
    Mateo, Joaquin
    CANCER RESEARCH, 2018, 78 (16) : 21 - 22
  • [6] PARP inhibitors in ovarian cancer: Sensitivity prediction and resistance mechanisms
    Jiang, Xuan
    Li, Xiaoying
    Li, Weihua
    Bai, Huimin
    Zhang, Zhenyu
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2019, 23 (04) : 2303 - 2313
  • [7] Transcription-replication conflicts underlie sensitivity to PARP inhibitors
    Petropoulos, Michalis
    Karamichali, Angeliki
    Rossetti, Giacomo G.
    Freudenmann, Alena
    Iacovino, Luca G.
    Dionellis, Vasilis S.
    Sotiriou, Sotirios K.
    Halazonetis, Thanos D.
    NATURE, 2024, 628 (8007) : 433 - +
  • [8] Enhancing tumor-targeting monoclonal antibodies therapy by PARP inhibitors
    Yelamos, Jose
    Galindo, Miguel
    Navarro, Judith
    Albanell, Joan
    Rovira, Ana
    Rojo, Federico
    Oliver, Javier
    ONCOIMMUNOLOGY, 2016, 5 (01):
  • [9] Recent Advances in Enhancing the Therapeutic Index of PARP Inhibitors in Breast Cancer
    Franchet, Camille
    Hoffmann, Jean-Sebastien
    Dalenc, Florence
    CANCERS, 2021, 13 (16)
  • [10] PARP-1 inhibitors and radiotherapy sensitivity: future prospects for therapy?
    Speers, Corey
    Feng, Felix Y.
    Pierce, Lori J.
    BREAST CANCER MANAGEMENT, 2014, 3 (03) : 281 - 296
12345